Reply to: ‘Clinical efficacy and safety of cefiderocol in the treatment of acute bacterial infections: a systematic review and meta-analysis of randomised controlled trials’
Main Authors: | P. Clevenbergh, E. Maillart, P.M. Tulkens |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Journal of Global Antimicrobial Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716521001387 |
Similar Items
-
In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
by: Michela Padovani, et al.
Published: (2023-04-01) -
In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany
by: Philipp Thelen, et al.
Published: (2022-03-01) -
Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
by: Ovidio De Filippo, et al.
Published: (2023-11-01) -
Efficacy and Safety of PSCK9 Inhibitors on Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Jiajing Zhao, et al.
Published: (2024-03-01) -
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials
by: Min-Hsiang Chuang, et al.
Published: (2023-05-01)